Comparison of essential medicines lists in 137 countries.

Comparison of essential medicines lists in 137 countries.

<p>Objective:To compare the medicines included in national essential medicines lists with the World Health Organization's (WHO's) Model list of essential medicines, and assess the extent to which countries' characteristics, such as WHO region, size and health care expenditure,...

書目詳細資料
Main Authors:	Persaud, N, Jiang, M, Shaikh, R, Bali, A, Oronsaye, E, Woods, H, Drozdzal, G, Rajakulasingam, Y, Maraj, D, Wadhawan, S, Umali, N, Wang, R, McCall, M, Aronson, J, Plüddemann, A, Moja, L, Magrini, N, Heneghan, C
格式:	Journal article
語言:	English
出版:	World Health Organisation 2019

相似書籍

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
由: Richards, GC, et al.
出版: (2020)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
由: Jordan D Jarvis, et al.
出版: (2019-01-01)

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
由: Carl Heneghan, et al.
出版: (2020-11-01)

Withdrawn medicines included in the essential medicines lists of 136 countries.
由: Onella Charles, et al.
出版: (2019-01-01)

A comparison of national essential medicines lists in the Americas
由: Liane Steiner, et al.
出版: (2020-01-01)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
由: Darshanand Maraj, et al.
出版: (2022-05-01)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
由: Benedikt Huttner, et al.
出版: (2022-02-01)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
由: Bernadette Cappello, et al.
出版: (2020-09-01)

Integrated Diagnosis in Africa’s Low- and Middle-Income Countries: What Is It, What Works, and for Whom? A Realist Synthesis
由: Gamuchirai Gwaza, et al.
出版: (2024-09-01)

Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
由: Muhamad Z. Ally, et al.
出版: (2020-05-01)

Ten essential papers for the practice of evidence-based medicine
由: Nunan, D, et al.
出版: (2017)

Associations between essential medicines and health outcomes for cardiovascular disease
由: Liane Steiner, et al.
出版: (2021-03-01)

Essential cancer medicines and cancer outcomes: Cross‐sectional study of 124 countries
由: Oghenefejiro (Theresa) Ikpeni, et al.
出版: (2023-11-01)

Święty Augustyn, List do Woluzjana (Epistula 137)
由: Andrzej P. Stefańczyk
出版: (2010-07-01)

Biologic medicine inclusion in 138 national essential medicines lists
由: Raphaël Kraus, et al.
出版: (2021-09-01)

A word about evidence: ‘rapid reviews’ or ‘restricted reviews’?
由: Aronson, J, et al.
出版: (2018)

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
由: Nav Persaud, et al.
出版: (2021-08-01)

Overview of systematic reviews: yoga as a therapeutic intervention for adults with acute and chronic health conditions.
由: McCall, M, et al.
出版: (2013)

Redefining rapid reviews: a flexible framework for restricted systematic reviews
由: Plüddemann, A, et al.
出版: (2018)

Tough decisions on essential medicines in 2015
由: Nicola Magrini, et al.

Cardiovascular disease essential medicines listing by countries: changes over time and association with health outcomes
由: Camila Heredia, et al.
出版: (2025-01-01)

Endocrinology and the essential list
由: Sanjay Kalra, et al.
出版: (2012-01-01)

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
由: Jennifer Walsh, et al.
出版: (2022-02-01)

Characteristics and efficacy of digital health education: An overview of systematic reviews
由: McCall, M, et al.
出版: (2018)

Transvaginal mesh failure: lessons for regulation of implantable devices.
由: Heneghan, C, et al.
出版: (2017)

Sodium efflux and essential hypertension.
由: Boon, N, et al.
出版: (1982)

Seasonal dynamic of content of 137Cs in mushrooms
由: N. E. Zarubina
出版: (2007-03-01)

On Essentiality and the World Health Organization's Model List of Essential Medicines
由: Victoria A. Marks, et al.
出版: (2017-06-01)

Catalogue of bias: novelty bias
由: Luo, Y, et al.
出版: (2023)

Editorial No. 137
由: El Editor
出版: (2017-02-01)

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
由: Heneghan, C, et al.
出版: (2017)

101 essential lists on assessment /
由: 464989 Rayment, Tabatha
出版: (2006)

Evaluation of CD137 and CD137L Transcript Levels and the Serum sCD137 in Immune-mediated Polyneuropathy
由: Shirin Torkestani, et al.
出版: (2023-03-01)

Accuracy of self-diagnosis in conditions commonly managed in primary care: diagnostic accuracy systematic review and meta-analysis
由: McLellan, JH, et al.
出版: (2023)

Desorption of 137Cs+ from mosses
由: Dragović Snežana D., et al.
出版: (2002-01-01)

Kinetics of 137Cs distribution in fish organism
由: V. V. Belyaev, et al.
出版: (2006-06-01)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
由: Asma Abubakr Mustafa, et al.
出版: (2010-12-01)

The crystal structure of d(GGATGGGAG): an essential part of the binding site for transcription factor IIIA.
由: McCall, M, et al.
出版: (1986)

137Cesium (137Cs) assessment in wild boars from northwestern Italy.
由: Daniele Pattono, et al.
出版: (2024-01-01)

137Cesium (137Cs) assessment in wild boars from northwestern Italy
由: Daniele Pattono, et al.
出版: (2024-01-01)